Healthcare


Genetic Technology Alert. Solid Tumor Detection with Fluorescent Targeting Peptides; Directed DNA Analysis-Based Prenatal Diagnostic Test for Trisomy Detection; Nutrigenetic Biomarkers for Obesity and Type 2 Diabetes

Share this:

This issue profiles solid tumor detection with fluorescent targeting peptides, directed DNA analysis-based prenatal diagnostic test for trisomy detection, and nutrigenetic biomarkers for obesity and type 2 diabetes. Strategic partnership details and some important patents have also been included.

Click headings to expand and collapse Published: 15 Jun 2012

Tools

Features of this research

Help Desk

Full list of offices


For more information and general enquiries, contact Frost & Sullivan near you.

North America
tel: +1.877.463.7678

Select a location near you..